PCP
CRL icon

Perimeter Capital Partners’s Charles River Laboratories CRL Stock Holding History

Perimeter Capital Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-36,228
Closed -$2.19M – 185
2014
Q1 		$2.19M Buy
36,228
+2,106
+6% +$123K 1.09% 4
2013
Q4 		$1.81M Sell
34,122
-42,428
-55% -$2.13M 0.89% 26
2013
Q3 		$3.54M Sell
76,550
-25,008
-25% -$1.15M 0.66% 52
2013
Q2 		$4.17M Buy
+101,558
New +$4.35M 0.8% 22

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perimeter Capital Partners's CRL Position: Q2 2014 in Review

Perimeter Capital Partners sold out of Charles River Laboratories (CRL) in Q2 2014, closing a stake of 36,228 shares — an estimated $2.19M sold.

Perimeter Capital Partners first reported a position in CRL in Q2 2013 and held it in 4 quarters. The position peaked at $4.17M in Q2 2013. 262 funds tracked by Wall St. Rank hold CRL as of Q2 2014.

  • Perimeter Capital Partners reported no remaining Charles River Laboratories position as of Q2 2014 after selling out during the quarter.
  • Perimeter Capital Partners sold 36,228 Charles River Laboratories shares in Q2 2014, an estimated $2.19M.
  • Perimeter Capital Partners first reported a position in Charles River Laboratories in Q2 2013 and held it in 4 quarters.
  • Perimeter Capital Partners's Charles River Laboratories position peaked at $4.17M in Q2 2013.
  • 262 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2014.

Based on Perimeter Capital Partners's 13F filing for Q2 2014, filed 12 Aug 2014.